
Phibro Animal Health
Yahoo Finance • 13 days ago
Phibro Animal declares $0.12 dividend
* Phibro Animal (PAHC [https://seekingalpha.com/symbol/PAHC]) declares $0.12/share quarterly dividend [https://seekingalpha.com/pr/20598416-phibro-animal-health-corporation-declares-quarterly-dividend]. * Forward yield [https://seeking... Full story
Yahoo Finance • last month
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks... Full story
Yahoo Finance • 2 months ago
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
E. Thomas Corcoran, Director of Phibro Animal Health Corporation(NASDAQ:PAHC), reported the acquisition of 10,000 shares of Common Stock at a weighted average price of $31.77 per share on May 29, 2026, according to a SEC Form 4 filing. Tr... Full story
Yahoo Finance • 2 months ago
Q1 Earnings Review: Branded Pharmaceuticals Stocks Led by Eli Lilly (NYSE:LLY)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at branded pharmaceuticals stocks, starting with Eli Lilly (NYSE:LLY). Looking ahe... Full story
Yahoo Finance • 2 months ago
1 Growth Stock with All-Star Potential and 2 We Question
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. Luckily for you, our job at StockStory is to h... Full story
Yahoo Finance • 3 months ago
Phibro's CEO transition puts this insider sale in context
Jack Bendheim, President and CEO of Phibro Animal Health Corporation(NASDAQ:PAHC), disclosed the indirect sale of 18,608 shares of Common Stock across multiple open-market transactions from May 5, 2026 through May 7, 2026, as reported in t... Full story
Yahoo Finance • 3 months ago
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings?
Over the past six months, Phibro Animal Health’s shares (currently trading at $36.72) have posted a disappointing 18.5% loss, well below the S&P 500’s 11.5% gain. This may have investors wondering how to approach the situation. Is now the... Full story
- GSPC
Mentioned:
Yahoo Finance • 3 months ago
Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million
Jack Bendheim, President and CEO of Phibro Animal Health Corporation(NASDAQ:PAHC), reported the indirect sale of 21,120 shares of Common Stock through BFI Co. LLC over multiple transactions on April 21, 2026, April 22, 2026, and April 23,... Full story
- ZTS
Mentioned:
Yahoo Finance • 4 months ago
Citi Just Made Zoetis Its Top Pick With a Buy Rating: Is the Pet Economy Boom the Best Trade of 2026?
Quick Read Zoetis (ZTS) received a Buy rating and $145 price target from Citi as top pick in animal health, citing the humanization of pets driving pain management spending in a market where 40% of dogs and cats suffer from osteoarthritis... Full story
Yahoo Finance • 4 months ago
Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings
[Heart Health Concept] Eoneren/E+ via Getty Images As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV [https://se... Full story
Yahoo Finance • 4 months ago
2 Growth Stocks Set to Flourishand 1 We Question
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajec... Full story
Yahoo Finance • 5 months ago
1 Healthcare Stock to Consider Right Now and 2 We Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks... Full story
Yahoo Finance • 5 months ago
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. The retreat in oil prices provided temporary relief to a market that was volatil... Full story
Yahoo Finance • 5 months ago
BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD is expanding its peripheral vascular p... Full story
Yahoo Finance • 6 months ago
Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion
Phibro Animal Health Corporation (NASDAQ:PAHC) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds.Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion The seventh... Full story
- MS
Mentioned:
Yahoo Finance • 7 months ago
Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA
Omeros Corporation OMER recently announced that the FDA approved its YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA), a frequent life-threatening condition that can oc... Full story
Yahoo Finance • 7 months ago
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
Glaukos Corporation GKOS is well-poised for growth on the back of the iDose TR launch and a robust product pipeline. However, stiff competition is a concern. Shares of this Zacks Rank #3 (Hold) company have gained 12.5% so far this year c... Full story
Yahoo Finance • 9 months ago
Wall Street Has a Positive Outlook on Phibro Animal Health Corporation (PAHC) Since Q1 2026 Results
Phibro Animal Health Corporation (NASDAQ:PAHC) is one of the Hottest Small Cap Stocks to Buy Now. On November 7, Ekaterina Knyazkova from J.P. Morgan raised the firm’s price target on Phibro Animal Health Corporation (NASDAQ:PAHC) from $4... Full story
Yahoo Finance • 10 months ago
Uncovering 3 Stocks Including Palo Alto Networks That May Be Trading Below Intrinsic Value Estimates
As the U.S. stock market begins the week on a high note, buoyed by gains across major indices and ongoing developments in trade and inflation data, investors are keenly observing opportunities amid economic uncertainties like the prolonged... Full story
Yahoo Finance • 10 months ago
Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Phibro Animal Health Corporation is one of them. Phibro Animal Health Corporation (NASDAQ:PAHC) reported strong growth in 2025, driven by expanded produc... Full story